U.S. market Closed. Opens in 2 hours 42 minutes

KPTI | Karyopharm Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue146.03M157.07M209.82M108.08M40.89M30.34M1.60M154.00K250.00K229.00K387.00K634.00K152.00K
Cost of Revenue4.94M5.21M3.40M2.71M2.41M161.37M107.27M86.94M97.74M60.13M28.45M14.10MN/A
Gross Profit141.09M151.86M206.42M105.38M38.49M-131.04M-105.67M-86.78M-97.49M-59.90M-28.07M-13.46M152.00K
Operating Expenses270.63M294.06M304.69M277.23M227.76M210.22M132.14M110.89M119.33M76.08M34.34M16.52M10.46M
Selling, General & Admin131.88M145.40M143.85M126.42M105.42M48.85M24.87M23.95M21.58M15.95M5.88M2.43M1.84M
Research & Development138.75M148.66M160.84M150.81M122.34M161.37M107.27M86.94M97.74M60.13M28.45M14.10M8.62M
Other Operating ExpensesN/A-83.00K-85.00K206.00K-50.00K-33.00K-81.00K10.00K-2.00K-27.00KN/AN/AN/A
Operating Income-129.54M-142.20M-98.27M-171.85M-189.28M-179.88M-130.54M-110.73M-119.08M-75.85M-33.95M-15.89M-10.31M
Other Expenses / Income-13.24M-22.72M-25.55M-24.11M-10.28M1.50M1.62M1.29M895.00K69.00K3.00K2.00KN/A
Before Tax Income-142.78M-164.92M-123.82M-195.96M-199.55M-178.38M-128.92M-109.44M-118.18M-75.78M-33.95M-15.89M-10.31M
Income Tax Expenses323.00K369.00K268.00K309.00K40.00K26.00K63.00K139.00K-895.00K-69.00K-3.00K-2.00KN/A
Net Income-143.10M-165.29M-124.09M-196.27M-199.59M-178.41M-128.98M-109.58M-118.18M-75.78M-33.95M-15.89M-10.31M
Interest Expenses23.82M25.00M26.05M27.14M15.65M2.49MN/AN/AN/A1.00KN/AN/AN/A
Basic Shares Outstanding114.22M81.87M75.22M72.04M61.96M56.78M45.90M37.52M35.62M31.14M6.07M2.39M1.00M
Diluted Shares Outstanding114.22M81.87M75.22M72.04M61.96M56.78M45.90M37.52M35.62M31.14M6.07M2.39M1.00M
EBITDA-118.42M-139.31M-96.98M-167.85M-182.93M-175.15M-128.21M-108.72M-118.44M-75.45M-33.80M-15.77M-10.23M
EBITDA Margin-81.09%-88.69%-46.22%-155.30%-447.34%-577.38%-7,988.04%-70,598.05%-47,376.80%-32,949.34%-8,734.63%-2,486.75%-6,728.95%
EBIT-118.95M-139.93M-97.77M-168.82M-183.90M-175.89M-128.92M-109.44M-119.08M-75.84M-33.95M-15.89M-10.31M
EBIT Margin-81.46%-89.08%-46.60%-156.20%-449.72%-579.80%-8,032.46%-71,063.64%-47,630.40%-33,120.09%-8,772.61%-2,506.31%-6,783.55%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙